Activation of AMPK prevents obesity and associated metabolic diseases through the promotion of glucose utilization, fatty acid oxidation, and mitochondrial biogenesis in skeletal muscle6. The gene discussed is PRKAA2; the disease is obesity due to melanocortin 4 receptor deficiency.